podium iq tracked 115 queries across 9 topics and 467 citations across 204 domains, sorted into the 5 categories below. Three of them, partner and hyperscaler pages, reviews and directories, and trade press, are earned or third party channels Adastra can influence directly: every profile claimed or case study published adds straight to citation share. That's where this report focuses.
The fastest, most controllable path to AI visibility runs through channels Adastra already partly controls: the hyperscaler partnerships it has already earned, and the owned site that should be proving them. Reviews and press are the two fastest secondary wins. Competitor content is real too, just slower to move, and it turns out to be a bigger share of the graph than it first looked (see below).
The categories above already include Adastra's full citation graph. We hand classified the 15 highest citation domains in what podium iq had left as Other, Community and Government (34 citations), folded them into Competitor Footprint, Reviews and Directories, or Press and Publications, and applied that same classification ratio to the roughly 97 remaining single citation domains we could not name individually. One source, sec.gov, was excluded entirely: it references Adastra Holdings Ltd. (CSE: XTRX), an unrelated, publicly traded cannabis company, not Adastra Corporation. Full detail and sources: Playbooks tab.
Every card below is checked against what Adastra has already done in market. "Already in place" is context; "Do next" is the to-do list. Click a segment for its card.
How Adastra's 467 tracked citations sort into the 5 categories used throughout this report, after folding in the long tail. Click any category for its top domains.
Adastra's market status facts and the long tail reclassification in this report draw on the public sources below.